Altimmune, Inc. (ALT) stock
ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.61−0.32 (-16.58%)
Close on Nov 12, 2026Market cap $313.17MP/E –Yield –
Altimmune enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Altimmune's enterprise value was $83.80M on Nov 11, 2026, against $306.52M a year earlier. Over the last 5 years it ranged from -$28.93M to $840.63M, with a median of $247.92M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $83.80M | -43.7% |
| 2025 | Dec 31, 2025 | $148.78M | -60.2% |
| 2024 | Dec 31, 2024 | $373.38M | -18.5% |
| 2023 | Dec 29, 2023 | $458.15M | -25.1% |
| 2022 | Dec 30, 2022 | $611.35M | +269.8% |
| 2021 | Dec 31, 2021 | $165.32M | -1.7% |
| 2020 | Dec 31, 2020 | $168.18M | – |
| 2019 | Dec 31, 2019 | -$8.46M | – |
| 2018 | Dec 31, 2018 | -$4.44M | -131.9% |
| 2017 | Dec 29, 2017 | $13.95M | -85.4% |
| 2016 | Dec 30, 2016 | $95.37M | -72.4% |
| 2015 | Feb 20, 2015 | $345.60M | +29.1% |
| 2013 | May 28, 2013 | $267.62M | +6.5% |
| 2012 | Dec 31, 2012 | $251.29M | +4.1% |
| 2011 | Dec 30, 2011 | $241.32M | – |
See a number that looks wrong?